E. Teugels

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation (2004)

SERMIJN, E, GOELEN, G, TEUGELS, E, KAUFMAN, L, BONDUELLE, M, NEYNS, B, ...

A BRCA-negative breast and ovarian cancer lineage with unexplained reversible repititive spontaneous abortion (2000)

Bernheim, F, Goelen, G, Teugels, E, Vergote, Ignace; U0002443, De Greve, F

The alpha E-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. (1999)

VERMEULEN, SJ, Nollet, Friedel, TEUGELS, E, VENNEKENS, KM, MALFAIT, F, Philippe, Jan, ...

A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families (1997)

Devilee, P., Bakker, E., Cornelisse, C.J., Vasen, H.F.A., ...

Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells. (1997)

VERMEULEN, SJ, NOLLET, F, TEUGELS, E, Philippe, Jan, Speleman, Franki, Van Roy, Frans, ...

Frequent deletion of chromosome-19 and a rare rearrangement of 19p13.3 involving the insulin-receptor gene in human ovarian-cancer (1995)

Amfo, K, Neyns, B, Teugels, E, Lissens, W, Bourgain, C, Desutter, P, ...

Human ovarian cancer cells usually have multiple specific chromosomal deletions which can be detected by cytogenetic analysis or molecular techniques. Tumour suppressor genes might be located in...

Quantitative in situ hybridization in neuro-endocrinology. Invited review (1991)

HOOGHE-PETERS, E, TEUGELS, E, Roels, Frank, VELKENIERS, B

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen, S L, Godwin, A K, Gershoni-Baruch, R, Schubert, E, Garber, J, Stoppa-Lyonnet, D, ...

Several BRCA2 mutations are found to occur in geographically diverse breast and ovarian cancer families. To investigate both mutation origin and mutation-specific phenotypes due to BRCA2, we...

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen, S L, Godwin, A K, Gershoni-Baruch, R, Schubert, E, Garber, J, Stoppa-Lyonnet, D, ...

Several BRCA2 mutations are found to occur in geographically diverse breast and ovarian cancer families. To investigate both mutation origin and mutation-specific phenotypes due to BRCA2, we...

A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families

Peelen, T., Van Vliet, M., Petrij-Bosch, A., Mieremet, R., Szabo, C., ...

We have identified 79 mutations in BRCA1 in a set of 643 Dutch and 23 Belgian hereditary breast and ovarian cancer families collected either for research or for clinical diagnostic purposes....

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects

Goelen, G, Teugels, E, Bonduelle, M, Neyns, B, De Greve, J

AIM—The initial risk assessments for BRCA1/2 mutation carriers and estimates of carrier frequencies were based on extended pedigrees with a large number of symptomatic subjects. When counselling...

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation

Sermijn, E, Goelen, G, Teugels, E, Kaufman, L, Bonduelle, M, Neyns, B, ...

The aE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene, 18, 1999,905-915.

Vermeulen, Stefan, NOLLET, F, TEUGELS, E, VENNEKENS, KM, MALFAIT, F, PHILIPPE, J, ...

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector

Vermeij, J, Zeinoun, Z, Neyns, B, Teugels, E, Bourgain, C, De Grève, J

Recombinant adeno-associated virus (rAAV) vectors have emerged as vehicles for gene therapy. In addition, anti-neoplastic properties have been attributed to wild-type AAV. To take advantage of both...